Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Medtronic
Express Scripts
Merck
Moodys

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DRONEDARONE HYDROCHLORIDE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Dronedarone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00174785 ↗ A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation Completed Sanofi Phase 3 2005-06-01 To assess the efficacy of dronedarone in preventing cardiovascular hospitalization or death from any cause in a population of high-risk patients with atrial fibrillation/atrial flutter (AF/AFL). To assess that dronedarone is well tolerated in this population.
NCT00259376 ↗ American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm Completed Sanofi Phase 3 2001-11-01 To assess the efficacy of dronedarone versus placebo for the maintenance of normal sinus rhythm after electrical, pharmacological or spontaneous conversion of atrial fibrillation/atrial flutter (AF/AFL). To assess the efficacy of dronedarone versus placebo on ventricular rate control in case of AF/AFL recurrence. To assess the efficacy of dronedarone versus placebo on AF/AFL-related symptoms.
NCT00259428 ↗ EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) Completed Sanofi Phase 3 2001-11-01 To assess the efficacy of dronedarone versus placebo for the maintenance of normal sinus rhythm after electrical, pharmacological or spontaneous conversion of atrial fibrillation/atrial flutter (AF/AFL). To assess the efficacy of dronedarone versus placebo on AF/AFL-related symptoms. To assess the efficacy of dronedarone versus placebo on ventricular rate control in case of AF/AFL recurrence.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dronedarone Hydrochloride

Condition Name

Condition Name for Dronedarone Hydrochloride
Intervention Trials
Atrial Fibrillation 23
Atrial Flutter 3
ICD SHOCKS 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dronedarone Hydrochloride
Intervention Trials
Atrial Fibrillation 25
Atrial Flutter 3
Recurrence 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dronedarone Hydrochloride

Trials by Country

Trials by Country for Dronedarone Hydrochloride
Location Trials
United States 88
Poland 16
Netherlands 10
Germany 10
United Kingdom 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dronedarone Hydrochloride
Location Trials
New Jersey 5
New York 4
California 4
Texas 4
Washington 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dronedarone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dronedarone Hydrochloride
Clinical Trial Phase Trials
Phase 4 10
Phase 3 9
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dronedarone Hydrochloride
Clinical Trial Phase Trials
Completed 15
Unknown status 5
Terminated 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dronedarone Hydrochloride

Sponsor Name

Sponsor Name for Dronedarone Hydrochloride
Sponsor Trials
Sanofi 17
Eastbourne General Hospital 2
National Institutes of Health (NIH) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dronedarone Hydrochloride
Sponsor Trials
Other 27
Industry 21
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Medtronic
Boehringer Ingelheim
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.